Gabapentin monotherapy: I. An 8-day, double-blind, dose-controlled, multicenter study in hospitalized patients with refractory complex partial or secondarily generalized seizures

Neurology

Volumn 49, Issue 3, 1997, Pages 739-745

  Bergey, G K ^a   Morris, H H ^g   Rosenfeld, W ^b   Blume, W T ^c   Penovich, P E ^d   Morrell, M J ^g   Leiderman, D B ^e   Crockatt, J G ^f   LaMoreaux, L ^f   Garofalo, Elizabeth ^f   Pierce, M ^f  

^a UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^b Compreh Epilepsy Care Ctr C ^*  (United States)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d MINNESOTA EPILEPSY GROUP   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f PFIZER INC   (United States)

^g Parke Davis Pharmaceutical Research ^*

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN;

ADOLESCENT; ADULT; ANTICONVULSANT ACTIVITY; ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG TOLERANCE; ELECTROENCEPHALOGRAM; FEMALE; FOCAL EPILEPSY; GRAND MAL SEIZURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; TELEMETRY; TREATMENT PLANNING;

EID: 0030870483     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.49.3.739     Document Type: Article

References (20)

1. UK Gabapentin Study Group. Gabapentin in partial epilepsy. Lancet 1990;335:1114-1117.
2. The US Gabapentin Study Group No. 5. Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study. Neurology 1993;43:2292-2298.
3. Anhut H, Ashman P, Feuerstein TJ, et al. Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study. Epilepsia 1994;35:795-801.
4. Taylor CP. Gabapentin: mechanisms of action. In: Levy RH, Mattson RH. Meldrum BS, eds. Antiepileptic drugs. 4th ed. New York: Raven Press, 1995:829-841.
5. Ojemann LM, Wilensky AJ, Temkin NR, Chmelir T, Ricker BA, Wallace J. Long-term treatment with gabapentin for partial epilepsy. Epilepsy Res 1992;13:159-165.
6. Pledger GW, Kramer LD. Clinical trials of investigational antiepileptic drugs: monotherapy designs. Epilepsia 1991;32: 716-721.
7. Cereghino JJ. Clinical trial design for antiepileptic drugs. Ann Neurol 1992;32:393-394.
8. Theodore WH, Albert P, Stertz B, et al. Felbamate monotherapy: implications for antiepileptic drug development. Epilepsia 1995;36:1105-1110.
9. Devinsky O, Faught RE, Wilder BJ, et al. Efficacy of felbamate monotherapy in patients undergoing presurgical evaluation of partial seizures. Epilepsy Res 1995;20:241-246.
10. Schachter SC, Vazquez B, Fisher R, et al. Monotherapy trial of oxcarbazepine for partial seizures in hospitalized presurgical patients [abstract]. Epilepsia 1996;37(suppl 5):202.
11. The US Gabapentin Study Group. The long-term safety and efficacy of gabapentin (Neurontin®) as add-on therapy in drug-resistant partial epilepsy. Epilepsy Res 1994;18:67-73.
12. Anhut H, Ashman PJ, Feuerstein TJ, et al. Long-term safety and efficacy of gabapentin (Neurontin) as add-on therapy in patients with refractory partial seizures. J Epilepsy 1995;8: 44-50.
13. Ramsay RE, Wilder BJ, Berger JR, Bruni J. A double-blind study comparing carbamazepine with phenytoin as initial seizure therapy in adults. Neurology 1983;33:904-910.
14. Wilder BJ, Ramsay RE, Murphy JV, Karas BJ, Marquardt K, Hammond EJ. Comparison of valproic acid and phenytoin in newly diagnosed tonic-clonic seizures. Neurology 1983;33: 1474-1476.
15. Temple R. Government viewpoint of clinical trials. Drug Info J 1982;16:10-17.
16. Leber PD. Hazards of inference: the active control investigation. Epilepsia 1989;30(suppl 1):S57-S63.
17. Lund L. Anticonvulsant effect of diphenylhydantoin relative to plasma levels: a prospective three-year study in ambulant patients with generalized epileptic seizures. Arch Neurol 1974;31:289-294.
18. Sachdeo R, Kramer LD, Rosenberg A, Sachdeo S. Felbamate monotherapy: controlled trial in patients with partial onset seizures. Ann Neurol 1992;32:386-392.
19. Faught E, Sachdeo RC, Remler MP, et al. Felbamate monotherapy for partial-onset seizures: an active-control trial. Neurology 1993;43:688-692.
20. Beydoun A, Fischer J, Labar DR, et al. Gabapentin monotherapy: II. A 26-week, double-blind, dose-controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures. Neurology 1997;49:746-752.